CSIMarket
 


Ardelyx Inc   (ARDX)
Other Ticker:  
 

Ardelyx Inc 's Tangible Leverage Ratio

ARDX's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth


Due to net new borrowings of 33.14%, Tangible Leverage Ratio fell to 0.78, above the Ardelyx Inc 's average Tangible Leverage Ratio.

Within Major Pharmaceutical Preparations industry in the forth quarter 2023, 39 other companies have achieved lower Tangible Leverage Ratio than Ardelyx Inc in the IV Quarter 2023. While Tangible Leverage Ratio total ranking has improved so far in the forth quarter 2023 to 429, from total ranking in the third quarter 2023 at 1047 .

Explain Tangible Leverage Ratio?
What is ARDX Market Share?
What are ARDX´s Total Liabilities?


ARDX Tangible Leverage Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Tangible Equity Change 149.5 % 260.4 % 95.39 % 19.02 % -17.89 %
Y / Y Total Liabilities Change 68.05 % 25.01 % 40.45 % 36.32 % -12.98 %
Tangible Leverage Ratio MRQ 0.78 0.51 0.73 0.93 1.16
ARDX's Total Ranking # 429 # 1047 # 1335 # 1321 #
Seq. Tangible Equity Change -12.74 % 52.42 % 27.55 % 47.06 % 26.05 %
Seq. Total Liabilities Change 33.14 % 7.23 % -0.15 % 17.9 % -0.96 %



Tangible Leverage Ratio forth quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 40
Healthcare Sector # 83
Overall Market # 429


Tangible Leverage Ratio Statistics
High Average Low
1.48 0.57 0.04
(Jun 30 2022)   (Jun 30 2015)




Financial Statements
Ardelyx Inc 's Tangible Equity $ 167 Millions Visit ARDX's Balance sheet
Ardelyx Inc 's Total Liabilities $ 131 Millions Visit ARDX's Balance sheet
Source of ARDX's Sales Visit ARDX's Sales by Geography


Cumulative Ardelyx Inc 's Tangible Leverage Ratio

ARDX's Tangible Leverage Ratio for the trailling 12 Months

ARDX Tangible Leverage Ratio

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Tangible Equity TTM Growth 149.5 % 260.4 % 95.39 % 19.02 % -17.89 %
Y / Y Total Liabilities TTM Growth 68.05 % 25.01 % 40.45 % 36.32 % -12.98 %
Tangible Leverage Ratio TTM 0.71 0.75 0.99 1.11 1.08
Total Ranking TTM # 2 # 37 # 1 # 1021 #
Seq. Tangible Equity TTM Growth -12.74 % 52.42 % 27.55 % 47.06 % 26.05 %
Seq. Total Liabilities TTM Growth 33.14 % 7.23 % -0.15 % 17.9 % -0.96 %


On the trailing twelve months basis Despite of the net new borrowings of 33.14% during the twelve months period ending in IV Quarter 2023 Ardelyx Inc has managed to decrease Tangible Leverage Ratio in the IV Quarter 2023 to 0.71, above the ARDX's average Tangible Leverage Ratio.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry ARDX recorded the lowest Tangible Leverage Ratio. While Tangible Leverage Ratio total ranking has improved so far to 2, from total ranking in previous 12 month period at 37.

Explain Tangible Leverage Ratio?
What is ARDX Market Share?
What are ARDX´s Total Liabilities?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 1
Within the Market # 2


trailing twelve months Tangible Leverage Ratio Statistics
High Average Low
1.11 0.61 0.09
(Dec 31 2022)   (June 30. 2016)




Companies with similar Tangible Leverage Ratio in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Tangible Leverage RatioDec 31 2023 MRQ Total LiabilitiesDec 31 2023 MRQ Tangible Equity
Biovie Inc   2.11 $ 13.981  Millions$ 6.623  Millions
Liquidia Corporation  1.78 $ 71.039  Millions$ 39.960  Millions
Summit Therapeutics Inc   1.65 $ 125.257  Millions$ 75.799  Millions
Xoma Corporation  1.64 $ 145.580  Millions$ 88.721  Millions
Ocular Therapeutix Inc   1.54 $ 139.916  Millions$ 91.131  Millions
Theriva Biologics inc   1.52 $ 17.528  Millions$ 11.508  Millions
Eton Pharmaceuticals Inc   1.51 $ 16.263  Millions$ 10.738  Millions
Lifevantage Corp  1.31 $ 35.375  Millions$ 26.918  Millions
2seventy Bio Inc   1.25 $ 310.126  Millions$ 248.706  Millions
Verastem inc   1.24 $ 71.185  Millions$ 57.374  Millions
23andme Holding Co  1.22 $ 231.023  Millions$ 189.010  Millions
Cara Therapeutics inc   1.20 $ 68.759  Millions$ 57.085  Millions
Talphera Inc   1.19 $ 6.290  Millions$ 5.286  Millions
Sonoma Pharmaceuticals Inc   1.18 $ 7.926  Millions$ 6.692  Millions
Sonnet Biotherapeutics Holdings Inc   1.07 $ 2.765  Millions$ 2.572  Millions
Arvinas Inc   0.98 $ 644.600  Millions$ 660.000  Millions
Royalty Pharma Plc  0.97 $ 9,772.199  Millions$ 10,084.289  Millions
Macrogenics Inc   0.96 $ 145.805  Millions$ 152.613  Millions
Entrada Therapeutics Inc   0.94 $ 226.832  Millions$ 242.360  Millions
Spyre Therapeutics Inc   0.86 $ 157.843  Millions$ 184.016  Millions
Immunic Inc   0.85 $ 24.729  Millions$ 28.931  Millions
Generation Bio Co   0.84 $ 171.630  Millions$ 203.128  Millions
Azitra Inc   0.81 $ 2.202  Millions$ 2.702  Millions
Moleculin Biotech Inc   0.81 $ 12.144  Millions$ 14.925  Millions
Ardelyx Inc   0.78 $ 130.763  Millions$ 166.816  Millions
Nurix Therapeutics Inc   0.77 $ 155.105  Millions$ 200.493  Millions
Harmony Biosciences Holdings inc   0.74 $ 244.962  Millions$ 329.884  Millions
Hutchmed china Limited  0.74 $ 549.232  Millions$ 743.387  Millions
Elite Pharmaceuticals Inc   0.71 $ 28.283  Millions$ 40.072  Millions
Paxmedica Inc   0.68 $ 2.295  Millions$ 3.385  Millions

Date modified: 2024-02-23T12:15:45+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com